Beijing Aosaikang Pharmaceutical Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Nippon Shinyaku Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Lakefront Biotherapeutics 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Apertura Gene Therapy LLC 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

NCT07661537 clinical trial report covering SHR-3079, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661797 clinical trial report covering LNF2105, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07660055 clinical trial report covering [177Lu]Lu-zolbetuximab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661095 clinical trial report covering CRD-3874, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07660341 clinical trial report covering CGB3002, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661446 clinical trial report covering Dronabinol, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661420 clinical trial report covering 211At-MABG, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07660432 clinical trial report covering SIM-0689, Phase 1, endpoints, sponsor, geography, readout timing and development white space.